NCT07835555Not yet recruitingPhase 4
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
Source: ClinicalTrials.gov · Last updated 23 Sept 2026
Brief summary (registry, in English)
Cigarette smoking is an important cause of illness and death among persons with HIV (PWH). This project will study the impact of adding contingency management (use of financial rewards) to receiving medications and counseling on promoting smoking abstinence and other health outcomes among PWH. As treatments will be provided by clinical pharmacists and other team members in HIV clinics, factors relevant for implementing this model to inform real-world practice will also be evaluated.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 794 (estimated)
- First submitted
- 16 Sept 2026
- Start date
- 30 Sept 2027
- Primary completion date
- 30 Sept 2030
- Lead sponsor
- Yale University
- Diseases
- HIV
- NCT number
- NCT07835555
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 794
- From 30 Sept 2027 to the primary completion date, 30 Sept 2030
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Life-threatening or unstable medical, surgical, or psychiatric condition;
Other
- Exclusive use of non-cigarette tobacco or nicotine products, including e-cigarettes;
- Self-report or urine testing confirming pregnancy, nursing, or trying to conceive;
- Anticipate being unable to return for follow-up for any reason, such as travel, planned procedure;
- Inability to provide \>1 form of contact information;
- Inability to read or understand English or Spanish.
Who the study is looking for
- Have been diagnosed with HIV;
- Receive care at one of the participating sites;
- Are \>18 years old;
- Have smoked \>100 cigarettes lifetime;
- Smoke everyday or some days;
- Smoke, on average, \>5 cigarettes per day; and
- Provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bridgeport Hospital Primary Care Center Infectious Disease Clinic Coordinator of this site? Confirm its status | Bridgeport | United States | Unknown status |
| Special Treatment And Research (STAR) at SUNY Downstate Coordinator of this site? Confirm its status | Brooklyn | United States | Unknown status |
| Center for Comprehensive Care at Jersey City Medical Center Coordinator of this site? Confirm its status | Jersey City | United States | Unknown status |
| Yale Center for Infectious Diseases Coordinator of this site? Confirm its status | New Haven | United States | Unknown status |
| Center for Comprehensive Care at St. Joseph's Health Coordinator of this site? Confirm its status | Paterson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.